MediciNova, Inc.
MNOV
$1.52
-$0.07-4.40%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | 0.00 |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | 0.00 |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | 0.00 |
SG&A Expenses | 1.28M | 1.45M | 1.40M | 1.35M | 839.30K |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 3.18M | 3.31M | 3.05M | 3.14M | 2.49M |
Operating Income | -3.18M | -3.31M | -3.05M | -3.14M | -2.49M |
Income Before Tax | -2.81M | -2.85M | -2.63M | -2.75M | -2.06M |
Income Tax Expenses | 5.50K | -- | -- | -- | 3.00K |
Earnings from Continuing Operations | -2.81M | -2.85M | -2.63M | -2.75M | -2.06M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -2.81M | -2.85M | -2.63M | -2.75M | -2.06M |
EBIT | -3.18M | -3.31M | -3.05M | -3.14M | -2.49M |
EBITDA | -3.18M | -3.30M | -3.04M | -3.13M | -2.48M |
EPS Basic | -0.06 | -0.06 | -0.05 | -0.06 | -0.04 |
Normalized Basic EPS | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 |
EPS Diluted | -0.06 | -0.06 | -0.05 | -0.06 | -0.04 |
Normalized Diluted EPS | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 |
Average Basic Shares Outstanding | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M |
Average Diluted Shares Outstanding | 49.05M | 49.05M | 49.05M | 49.05M | 49.05M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |